Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
2018.
Amoxicillin.
Reactions Weekly,
Vol. 1704,
Issue. 1,
p.
31.
Marrani, Edoardo
Burns, Jane C.
and
Cimaz, Rolando
2018.
How Should We Classify Kawasaki Disease?.
Frontiers in Immunology,
Vol. 9,
Issue. ,
Miyabe, Chie
Miyabe, Yoshishige
Bricio-Moreno, Laura
Lian, Jeffrey
Rahimi, Rod A.
Miura, Noriko N.
Ohno, Naohito
Iwakura, Yoichiro
Kawakami, Tamihiro
and
Luster, Andrew D.
2019.
Dectin-2–induced CCL2 production in tissue-resident macrophages ignites cardiac arteritis.
Journal of Clinical Investigation,
Vol. 129,
Issue. 9,
p.
3610.
Endo, Hirohisa
Dohi, Tomotaka
Dohi, Shizuyuki
Wada, Hideki
Doi, Shinichiro
Kato, Yoshiteru
Okai, Iwao
Iwata, Hiroshi
Okazaki, Shinya
Isoda, Kikuo
Yamamoto, Taira
Miyauchi, Katsumi
Amano, Atsushi
Daida, Hiroyuki
and
Cai, Zhejun
2019.
Clinical indicators and coronary angiographic features of expansive arterial remodelling in patients with abdominal aortic aneurysms.
PLOS ONE,
Vol. 14,
Issue. 7,
p.
e0219730.
Bettiol, Alessandra
Lopalco, Giuseppe
Emmi, Giacomo
Cantarini, Luca
Urban, Maria Letizia
Vitale, Antonio
Denora, Nunzio
Lopalco, Antonio
Cutrignelli, Annalisa
Lopedota, Angela
Venerito, Vincenzo
Fornaro, Marco
Vannacci, Alfredo
Rigante, Donato
Cimaz, Rolando
and
Iannone, Florenzo
2019.
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.
International Journal of Molecular Sciences,
Vol. 20,
Issue. 8,
p.
1898.
Dinarello, Charles Anthony
2019.
The IL-1 family of cytokines and receptors in rheumatic diseases.
Nature Reviews Rheumatology,
Vol. 15,
Issue. 10,
p.
612.
Maggio, M. C.
Cimaz, R.
Alaimo, A.
Comparato, C.
Di Lisi, D.
and
Corsello, G.
2019.
Kawasaki disease triggered by parvovirus infection: an atypical case report of two siblings.
Journal of Medical Case Reports,
Vol. 13,
Issue. 1,
Friedman, Kevin G.
and
Jone, Pei-Ni
2020.
Update on the Management of Kawasaki Disease.
Pediatric Clinics of North America,
Vol. 67,
Issue. 5,
p.
811.
Nakra, Natasha
Blumberg, Dean
Herrera-Guerra, Angel
and
Lakshminrusimha, Satyan
2020.
Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management.
Children,
Vol. 7,
Issue. 7,
p.
69.
Loke, Yue-Hin
Berul, Charles I.
and
Harahsheh, Ashraf S.
2020.
Multisystem inflammatory syndrome in children: Is there a linkage to Kawasaki disease?.
Trends in Cardiovascular Medicine,
Vol. 30,
Issue. 7,
p.
389.
Maniscalco, Valerio
Abu-Rumeileh, Sarah
Mastrolia, Maria Vincenza
Marrani, Edoardo
Maccora, Ilaria
Pagnini, Ilaria
and
Simonini, Gabriele
2020.
The off-label use of anakinra in pediatric systemic autoinflammatory diseases.
Therapeutic Advances in Musculoskeletal Disease,
Vol. 12,
Issue. ,
p.
1759720X2095957.
Williams, Maegan
Nagaraju, Lakshmi
and
Gorelik, Mark
2020.
Complete Regression of Giant Aneurysms in an Infant with Delayed Diagnosis and Refractory Kawasaki Disease via Combination Anticytokine Therapy: Case Report and Review of Similar Cases.
Case Reports in Rheumatology,
Vol. 2020,
Issue. ,
p.
1.
Soni, Priya R.
Noval Rivas, Magali
and
Arditi, Moshe
2020.
A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis.
Current Rheumatology Reports,
Vol. 22,
Issue. 2,
Ferrara, Giovanna
Giani, Teresa
Caparello, Maria Costanza
Farella, Carla
Gamalero, Lisa
and
Cimaz, Rolando
2020.
Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review.
Pediatric Drugs,
Vol. 22,
Issue. 6,
p.
645.
Henderson, Lauren A.
Canna, Scott W.
Friedman, Kevin G.
Gorelik, Mark
Lapidus, Sivia K.
Bassiri, Hamid
Behrens, Edward M.
Ferris, Anne
Kernan, Kate F.
Schulert, Grant S.
Seo, Philip
F. Son, Mary Beth
Tremoulet, Adriana H.
Yeung, Rae S. M.
Mudano, Amy S.
Turner, Amy S.
Karp, David R.
and
Mehta, Jay J.
2020.
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1.
Arthritis & Rheumatology,
Vol. 72,
Issue. 11,
p.
1791.
Noval Rivas, Magali
and
Arditi, Moshe
2020.
Kawasaki disease: pathophysiology and insights from mouse models.
Nature Reviews Rheumatology,
Vol. 16,
Issue. 7,
p.
391.
Halyabar, Olha
Friedman, Kevin G.
Sundel, Robert P.
Baker, Annette L.
Chang, Margaret H.
Gould, Patrick W.
Newburger, Jane W.
and
Son, Mary Beth F.
2021.
Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms.
Pediatric Rheumatology,
Vol. 19,
Issue. 1,
Maruyama, Daisuke
Kocatürk, Begüm
Lee, Youngho
Abe, Masanori
Lane, Malcolm
Moreira, Debbie
Chen, Shuang
Fishbein, Michael C.
Porritt, Rebecca A.
Noval Rivas, Magali
and
Arditi, Moshe
2021.
MicroRNA-223 Regulates the Development of Cardiovascular Lesions in LCWE-Induced Murine Kawasaki Disease Vasculitis by Repressing the NLRP3 Inflammasome.
Frontiers in Pediatrics,
Vol. 9,
Issue. ,
Stefania, Silvia
Colia, Ripalta
Cinzia, Rotondo
Corrado, Addolorata
and
Cantatore, Francesco Paolo
2021.
Off-label use of anti-IL-1 drugs in rheumatic diseases.
International Journal of Immunopathology and Pharmacology,
Vol. 35,
Issue. ,
p.
205873842110065.
Leung, Donald Y. M.
and
Schlievert, Patrick M.
2021.
Kawasaki syndrome: role of superantigens revisited.
The FEBS Journal,
Vol. 288,
Issue. 6,
p.
1771.